Cargando…
SARS-CoV-2 Vaccines in Patients With Multiple Myeloma
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892292/ https://www.ncbi.nlm.nih.gov/pubmed/33623886 http://dx.doi.org/10.1097/HS9.0000000000000547 |
_version_ | 1783652816823255040 |
---|---|
author | Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Korompoki, Eleni Terpos, Evangelos Dimopoulos, Meletios A. |
author_facet | Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Korompoki, Eleni Terpos, Evangelos Dimopoulos, Meletios A. |
author_sort | Gavriatopoulou, Maria |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7892292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-78922922021-02-22 SARS-CoV-2 Vaccines in Patients With Multiple Myeloma Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Korompoki, Eleni Terpos, Evangelos Dimopoulos, Meletios A. Hemasphere Perspective Lippincott Williams & Wilkins 2021-02-17 /pmc/articles/PMC7892292/ /pubmed/33623886 http://dx.doi.org/10.1097/HS9.0000000000000547 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Perspective Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Korompoki, Eleni Terpos, Evangelos Dimopoulos, Meletios A. SARS-CoV-2 Vaccines in Patients With Multiple Myeloma |
title | SARS-CoV-2 Vaccines in Patients With Multiple Myeloma |
title_full | SARS-CoV-2 Vaccines in Patients With Multiple Myeloma |
title_fullStr | SARS-CoV-2 Vaccines in Patients With Multiple Myeloma |
title_full_unstemmed | SARS-CoV-2 Vaccines in Patients With Multiple Myeloma |
title_short | SARS-CoV-2 Vaccines in Patients With Multiple Myeloma |
title_sort | sars-cov-2 vaccines in patients with multiple myeloma |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892292/ https://www.ncbi.nlm.nih.gov/pubmed/33623886 http://dx.doi.org/10.1097/HS9.0000000000000547 |
work_keys_str_mv | AT gavriatopouloumaria sarscov2vaccinesinpatientswithmultiplemyeloma AT ntanasisstathopoulosioannis sarscov2vaccinesinpatientswithmultiplemyeloma AT korompokieleni sarscov2vaccinesinpatientswithmultiplemyeloma AT terposevangelos sarscov2vaccinesinpatientswithmultiplemyeloma AT dimopoulosmeletiosa sarscov2vaccinesinpatientswithmultiplemyeloma |